Sort   by:  
 Page size 
UnknownCOVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis.
Not available
S-EPMC11806888 | biostudies-literature
UnknownSubcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis.
Not available
S-EPMC6549305 | biostudies-literature
UnknownA randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
Not available
S-EPMC5947135 | biostudies-literature
UnknownEarly nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy.
Not available
S-EPMC6031191 | biostudies-literature
UnknownLolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.
Not available
S-EPMC6032848 | biostudies-literature
UnknownUltra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis.
Not available
S-EPMC5763416 | biostudies-literature
Sort   by:  
 Page size